Skip to content
HowShorted

Fulgent Genetics, Inc. short interest in 2022

In 2022, Fulgent Genetics, Inc.'s disclosed short interest ran from 7.25% of shares outstanding on 14 Jan 2022 to 3.48% on 30 Dec 2022, a change of -3.77 percentage points. The year's high was 7.25% on 14 Jan 2022 and its low 3.48% on 30 Dec 2022, averaging 4.97% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.17 days on 15 Jul 2022. Full history: Fulgent Genetics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Fulgent Genetics, Inc. in 2022

2022 in figures

Start of year
7.25% (14 Jan 2022)
End of year
3.48% (30 Dec 2022)
Change
-3.77 pp
High
7.25% (14 Jan 2022)
Low
3.48% (30 Dec 2022)
Average
4.97%
Highest days to cover
7.17 (15 Jul 2022)
SEC filings marked
9

Every report in 2022

Fulgent Genetics, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20227.25%3.72
31 Jan 20226.65%3.00
15 Feb 20225.65%4.32
28 Feb 20225.47%3.28results (8-K), 10-K filed
15 Mar 20225.06%3.04
31 Mar 20225.10%4.44
14 Apr 20225.85%6.14
29 Apr 20225.66%4.76results (8-K)
13 May 20225.68%3.92results (8-K), 10-Q filed
31 May 20225.65%4.05
15 Jun 20225.04%4.33
30 Jun 20224.77%4.45
15 Jul 20224.95%7.17
29 Jul 20224.96%5.70
15 Aug 20224.59%3.7610-Q filed, results (8-K)
31 Aug 20224.60%4.03
15 Sep 20224.45%3.75
30 Sep 20224.32%5.18
14 Oct 20224.22%4.96
31 Oct 20224.02%5.49
15 Nov 20223.94%3.1210-Q filed, results (8-K)
30 Nov 20223.88%5.17
15 Dec 20224.03%4.61
30 Dec 20223.48%3.01

See also: Fulgent Genetics, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.